SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-18-031925
Filing Date
2018-05-10
Accepted
2018-05-10 06:55:39
Documents
4
Period of Report
2018-05-09

Document Format Files

Seq Description Document Type Size
1 6-K a18-13206_16k.htm 6-K 18035
2 EX-99.1 a18-13206_1ex99d1.htm EX-99.1 252355
3 EX-99.2 a18-13206_1ex99d2.htm EX-99.2 26887
4 GRAPHIC g132061moi001.jpg GRAPHIC 2279
  Complete submission text file 0001104659-18-031925.txt   301591
Mailing Address DARWINWEG 24 LEIDEN P7 2333CR
Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 18820425
SIC: 2834 Pharmaceutical Preparations